VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
VEROVenus Concept Inc.
$0.27$498989
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

VERO logoVenus Concept Inc.(VERO)Earnings, Financials & Key Ratios

VERO•NASDAQ
Price updated Apr 24, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryAesthetics, dermatology, and wound care
AboutVenus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.Show more
  • Revenue$65M-15.1%
  • EBITDA-$23M+3.7%
  • Net Income-$47M-26.2%
  • EPS (Diluted)-66.28-869.0%
  • Gross Margin68.34%
  • EBITDA Margin-35.93%-13.4%
  • Operating Margin-41.93%-13.1%
  • Net Margin-72.49%-48.6%
  • ROE-1655.95%

VERO Key Insights

Venus Concept Inc. (VERO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Share count reduced 87.0% through buybacks
  • ✓Trading at only 0.1x book value

✗Weaknesses

  • ✗High debt to equity ratio of 15.2x
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 2 (bottom 2%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Sales declining 10.1% over 5 years
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when VERO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

VERO Price & Volume

Venus Concept Inc. (VERO) stock price & volume — 10-year historical chart

Loading chart...

VERO Growth Metrics

Venus Concept Inc. (VERO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-10.1%
3 Years-15.01%
TTM-12.39%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-8.91%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-209.73%

Return on Capital

10 Years-71.94%
5 Years-37.54%
3 Years-41.93%
Last Year-54.16%

VERO Peer Comparison

Venus Concept Inc. (VERO) competitors in Aesthetics, dermatology, and wound care — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
INMD logoINMDInMode Ltd.Direct Competitor849.01M13.409.37-6.16%23.27%13.28%0.02
SSKN logoSSKNSTRATA Skin Sciences, Inc.Direct Competitor806.68K0.14-0.10-8.54%-21.13%-360.33%5.59
LASE logoLASELaser Photonics CorporationDirect Competitor39.74M2.32-2.27131.96%-268.71%-44.07%
HIMS logoHIMSHims & Hers Health, Inc.Product Competitor7.79B35.4769.5559%-0.56%-2.48%2.34
SKIN logoSKINThe Beauty Health CompanyProduct Competitor85.9M0.66-4.14-10.02%-2.03%-9.41%6.20
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
MDT logoMDTMedtronic plcSupply Chain101.86B79.3421.983.62%13%9.49%0.59
SYK logoSYKStryker CorporationSupply Chain117.88B307.8036.6411.16%12.92%15.04%0.66

Compare VERO vs Peers

Venus Concept Inc. (VERO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs INMD

Most directly comparable listed peer for VERO.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare VERO against a more recognizable public peer.

Peer Set

Compare Top 5

vs INMD, SSKN, LASE, HIMS

VERO Income Statement

Venus Concept Inc. (VERO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue
15.6M21.3M21.96M110.41M78.01M105.62M99.5M76.35M64.83M58.88M
Revenue Growth %
-9.46%36.52%3.09%402.85%-29.34%35.39%-5.8%-23.26%-15.09%-12.39%
Cost of Goods Sold
10.43M12.15M12.45M33.75M26.62M31.53M33.53M24.19M20.53M20.98M
COGS % of Revenue
66.87%57.05%56.7%30.57%34.13%29.85%33.7%31.68%31.66%-
Gross Profit
5.17M▲ 0%
9.15M▲ 77.0%
9.51M▲ 3.9%
76.65M▲ 706.4%
51.39M▼ 33.0%
74.09M▲ 44.2%
65.97M▼ 11.0%
52.17M▼ 20.9%
44.31M▼ 15.1%
37.89M▲ 0%
Gross Margin %
33.13%42.95%43.3%69.43%65.87%70.15%66.3%68.32%68.34%64.36%
Gross Profit Growth %
9.58%76.96%3.92%706.36%-32.96%44.18%-10.96%-20.92%-15.07%-
Operating Expenses
24.1M26.43M35.41M106.93M119.29M88.86M100.85M80.48M71.49M72.63M
OpEx % of Revenue
154.49%124.1%161.29%96.85%152.91%84.13%101.36%105.4%110.27%-
Selling, General & Admin
16.63M19.29M27.04M98.9M84.08M81.99M89.89M72.28M64.8M66.96M
SG&A % of Revenue
106.58%90.59%123.15%89.58%107.78%77.63%90.35%94.66%99.95%-
Research & Development
7.47M7.13M8.37M8.03M7.75M9.65M10.95M8.2M6.69M5.66M
R&D % of Revenue
47.91%33.5%38.14%7.28%9.94%9.13%11.01%10.74%10.32%-
Other Operating Expenses
000027.45M-2.77M0000
Operating Income
-18.93M▲ 0%
-17.28M▲ 8.7%
-25.91M▼ 49.9%
-30.28M▼ 16.9%
-67.9M▼ 124.2%
-14.77M▲ 78.3%
-34.88M▼ 136.2%
-28.31M▲ 18.8%
-27.18M▲ 4.0%
-34.74M▲ 0%
Operating Margin %
-121.36%-81.15%-117.99%-27.42%-87.03%-13.98%-35.05%-37.08%-41.93%-59%
Operating Income Growth %
7.76%8.72%-49.9%-16.88%-124.25%78.25%-136.18%18.83%3.97%-
EBITDA
-18.28M-16.71M-24.57M-28.24M-63.09M-9.91M-30.41M-24.19M-23.3M-30.89M
EBITDA Margin %
-117.17%-78.45%-111.89%-25.58%-80.88%-9.39%-30.57%-31.69%-35.93%-52.47%
EBITDA Growth %
7.05%8.59%-47.03%-14.95%-123.44%84.29%-206.8%20.45%3.72%-27.92%
D&A (Non-Cash Add-back)
654K574K1.34M2.04M4.8M4.85M4.46M4.12M3.89M3.84M
EBIT
-19.36M-15.76M-26.45M-32.59M-73.29M-17.89M-39.74M-30.23M-39.93M-49.26M
Net Interest Income
-2.48M-2.03M-2.22M-7.85M-8.34M-4.96M-4.56M-6.89M-7.66M-5.08M
Interest Income
000-297K000000
Interest Expense
2.48M2.03M2.22M7.55M8.34M4.96M4.56M6.89M7.66M5.08M
Other Income/Expense
-2.91M-504K-2.77M-10.16M-13.74M-8.08M-9.43M-8.81M-20.4M-19.61M
Pretax Income
-21.85M▲ 0%
-17.79M▲ 18.6%
-28.68M▼ 61.2%
-40.44M▼ 41.0%
-81.64M▼ 101.9%
-22.85M▲ 72.0%
-44.31M▼ 93.9%
-37.12M▲ 16.2%
-47.58M▼ 28.2%
-54.35M▲ 0%
Pretax Margin %
-140.04%-83.51%-130.62%-36.63%-104.64%-21.63%-44.53%-48.62%-73.39%-92.31%
Income Tax
056K47K1.86M1.18M-707K-722K-71K-611K325K
Effective Tax Rate %
0%-0.31%-0.16%-4.59%-1.45%3.09%1.63%0.19%1.28%-0.6%
Net Income
-21.85M▲ 0%
-17.84M▲ 18.3%
-28.73M▼ 61.0%
-40.62M▼ 41.4%
-81.71M▼ 101.2%
-23.01M▲ 71.8%
-43.7M▼ 89.9%
-37.25M▲ 14.8%
-47M▼ 26.2%
-54.61M▲ 0%
Net Margin %
-140.04%-83.78%-130.83%-36.79%-104.73%-21.79%-43.92%-48.79%-72.49%-92.76%
Net Income Growth %
4.9%18.33%-61%-41.4%-101.15%71.83%-89.89%14.76%-26.16%-8.91%
Net Income (Continuing)
-21.85M-17.84M-28.73M-42.3M-82.82M-22.14M-43.58M-37.05M-46.97M-54.67M
Discontinued Operations
0000000000
Minority Interest
004.02M2.5M-471K653K645K570K469K461K
EPS (Diluted)
-213.23▲ 0%
-152.86▲ 28.3%
-192.87▼ 26.2%
-74.49▲ 61.4%
-33.92▲ 54.5%
-6.34▲ 81.3%
-9.91▼ 56.3%
-6.84▲ 31.0%
-66.28▼ 869.0%
-29.38▲ 0%
EPS Growth %
4.9%28.31%-26.17%61.38%54.46%81.31%-56.31%30.98%-869.01%-209.73%
EPS (Basic)
-213.23-152.86-192.87-74.49-33.92-6.34-9.91-6.84-66.28-
Diluted Shares Outstanding
102.45K116.72K148.94K567.8K2.44M3.63M4.4M5.44M709K1.86M
Basic Shares Outstanding
102.45K116.72K148.94K567.8K2.44M3.63M4.4M5.44M709K1.86M
Dividend Payout Ratio
----------

VERO Balance Sheet

Venus Concept Inc. (VERO) balance sheet — assets, liabilities & shareholders' equity

MetricDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets
17.94M31.73M29.49M99.7M115.4M110.28M83.71M66.44M48.51M45.82M
Cash & Short-Term Investments
11.91M23.55M16.12M15.67M34.3M30.88M11.57M5.4M4.27M5.93M
Cash Only
11.91M23.55M16.12M15.67M34.3M30.88M11.57M5.4M4.27M5.93M
Short-Term Investments
0000000000
Accounts Receivable
2.48M3.86M6.57M58.98M56.35M49.65M39.49M30.57M19.33M16.89M
Days Sales Outstanding
58.0566.22109.2194.98263.66171.56144.88146.15108.83108.53
Inventory
2.74M2.76M5.52M18.84M17.76M26.21M29.79M28.68M17.56M21.77M
Days Inventory Outstanding
95.9582.94161.89203.78243.47303.43324.29432.74312.26316.7
Other Current Assets
01.56M03.1M2.17M808K1.17M503K495K435K
Total Non-Current Assets
1.56M1.24M1.48M91.42M45.12M47.1M41.67M27.21M19.67M15.8M
Property, Plant & Equipment
1.46M1.14M1.3M4.65M3.54M2.67M7.72M5.84M4.22M3.33M
Fixed Asset Turnover
10.69x18.71x16.90x23.75x22.04x39.57x12.89x13.08x15.37x15.59x
Goodwill
002.6M27.45M000000
Intangible Assets
00022.34M18.86M15.39M11.92M8.45M4.97M2.38M
Long-Term Investments
100K100K38.2M35.66M21.15M27.71M20.04M11.32M8.53M27.33M
Other Non-Current Assets
00-40.92M710K685K1.04M1.04M574K488K523K
Total Assets
19.5M▲ 0%
32.97M▲ 69.1%
30.97M▼ 6.1%
191.13M▲ 517.1%
160.53M▼ 16.0%
157.37M▼ 2.0%
125.38M▼ 20.3%
93.65M▼ 25.3%
68.18M▼ 27.2%
61.62M▲ 0%
Asset Turnover
0.80x0.65x0.71x0.58x0.49x0.67x0.79x0.82x0.95x0.92x
Asset Growth %
-26.36%69.09%-6.06%517.08%-16.01%-1.96%-20.33%-25.3%-27.2%-88.24%
Total Current Liabilities
13.05M14.05M9.38M48.17M32.52M34.72M39.59M31.16M30.29M50.65M
Accounts Payable
1.74M2.04M3.81M9.4M6.32M8.42M8.03M9.04M6.48M7.11M
Days Payables Outstanding
60.8961.4111.85101.6686.6797.4687.46136.39115.3116.59
Short-Term Debt
7.45M7.73M49K7.79M0543K9.54M5.75M8.27M26.32M
Deferred Revenue (Current)
1.52M1.52M1.41M6.44M3.7M4.71M4.16M2.54M1.86M7.58M
Other Current Liabilities
01.13M1.77M3.14M7.53M18.99M15.5M11.21M6.57M9.94M
Current Ratio
1.37x2.26x3.14x2.07x3.55x3.18x2.11x2.13x1.60x0.90x
Quick Ratio
1.16x2.06x2.56x1.68x3.00x2.42x1.36x1.21x1.02x0.47x
Cash Conversion Cycle
93.1187.76159.25297.09420.46377.54381.72442.5305.79308.63
Total Non-Current Liabilities
149.99M5.73M20.01M66.28M84.25M81.06M77.05M75.94M35.06M7.84M
Long-Term Debt
13M5.27M19.42M61.23M79.6M77.33M70M70.79M31.44M5M
Capital Lease Obligations
0000004.22M3.16M2M6.69M
Deferred Tax Liabilities
001.89M1.02M811K46K015K00
Other Non-Current Liabilities
136.99M459K594K2.35M2.06M2.33M1.86M1.31M1.26M1.11M
Total Liabilities
163.04M19.78M29.39M114.45M116.76M115.78M116.64M107.1M65.35M58.49M
Total Debt
20.45M13M19.47M69.02M79.6M77.87M83.77M79.7M43.03M32.67M
Net Debt
8.54M-10.54M3.35M53.35M45.3M46.99M72.2M74.3M38.76M26.73M
Debt / Equity
-0.99x3.47x0.90x1.82x1.87x9.59x-15.16x10.42x
Debt / EBITDA
----------1.06x
Net Debt / EBITDA
----------0.87x
Interest Coverage
-7.62x-8.53x-11.65x-4.01x-8.14x-2.98x-7.65x-4.11x-3.55x-9.69x
Total Equity
-143.54M▲ 0%
13.19M▲ 109.2%
5.6M▼ 57.5%
76.68M▲ 1268.3%
43.76M▼ 42.9%
41.6M▼ 4.9%
8.74M▼ 79.0%
-13.45M▼ 253.9%
2.84M▲ 121.1%
3.13M▲ 0%
Equity Growth %
-17.46%109.19%-57.53%1268.27%-42.93%-4.95%-78.99%-253.91%121.1%126.56%
Book Value per Share
-1401.10113.0437.63135.0417.9211.461.99-2.474.001.69
Total Shareholders' Equity
-143.54M13.19M1.58M74.18M44.23M40.94M8.09M-14.02M2.37M2.67M
Common Stock
2K3K4K24K26K27K29K30K30K31K
Retained Earnings
-146.65M-164.49M-193.21M-75.69M-157.39M-180.41M-224.1M-261.9M-308.9M-355.55M
Treasury Stock
0000000000
Accumulated OCI
14K-79K-50K0000000
Minority Interest
004.02M2.5M-471K653K645K570K469K461K

VERO Cash Flow Statement

Venus Concept Inc. (VERO) cash flow — operating, investing & free cash flow history

MetricDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations
-16.16M-19.26M-28.7M-39.59M-28.65M-19.77M-26.98M-12.86M-11.07M-20.45M
Operating CF Margin %
-103.62%-90.42%-130.71%-35.86%-36.72%-18.72%-27.12%-16.84%-17.07%-
Operating CF Growth %
32.98%-19.13%-49.04%-37.97%27.64%30.99%-36.46%52.34%13.94%-880.5%
Net Income
-21.85M-17.84M-28.73M-42.3M-82.82M-22.14M-43.58M-37.05M-46.97M-54.61M
Depreciation & Amortization
654K574K813K2.04M4.8M4.85M4.46M4.12M3.89M3.85M
Stock-Based Compensation
466K465K667K2.16M2.14M2.07M2.1M1.57M1.04M570K
Deferred Taxes
392K-1.43M1.95M-1.13M-438K-165K-709K-69K-443K873K
Other Non-Cash Items
737K578K470K12.47M55.38M764K10.33M6.94M19.34M24.3M
Working Capital Changes
3.43M-1.6M-3.87M-12.84M-7.72M-5.15M417K11.64M12.08M4.65M
Change in Receivables
-987K-1.38M-4.48M-21.09M93K-869K9.86M14.89M12.49M1.56M
Change in Inventory
2.89M-19K-2.76M6.43M-1.02M-4.26M-5.78M-324K4.46M1.85M
Change in Payables
709K246K1.8M-5.97M-2.98M2.1M-385K1M-2.21M80K
Cash from Investing
-1.17M1.62M-1.01M6.38M-2.39M-552K-336K-116K-123K-294K
Capital Expenditures
-1.17M-229K-1.01M-1.12M-291K-512K-336K-116K-123K-294K
CapEx % of Revenue
7.52%1.08%4.58%1.02%0.37%0.48%0.34%0.15%0.19%0.5%
Acquisitions
2K0-7.5M0-2.1M-40K0000
Investments
----------
Other Investing
2K1.85M07.51M000000
Cash from Financing
12.11M29.37M22.24M42.2M49.67M16.82M8.01M6.8M10.06M22.19M
Debt Issued (Net)
0-3M6.28M16.42M1.42M-738K-543K09.2M18.91M
Equity Issued (Net)
1000K1000K1000K01000K1000K1000K1000K987K1M
Dividends Paid
0000000000
Share Repurchases
0000000000
Other Financing
41K43K392K25.78M-911K817K-101K-275K-126K0
Net Change in Cash
-5.22M▲ 0%
11.64M▲ 322.9%
-7.44M▼ 163.9%
8.99M▲ 220.8%
18.63M▲ 107.2%
-3.5M▼ 118.8%
-19.31M▼ 451.0%
-6.17M▲ 68.0%
-1.13M▲ 81.8%
1.44M▲ 0%
Free Cash Flow
-17.34M▲ 0%
-19.48M▼ 12.4%
-29.7M▼ 52.5%
-40.72M▼ 37.1%
-28.94M▲ 28.9%
-20.28M▲ 29.9%
-27.32M▼ 34.7%
-12.97M▲ 52.5%
-11.19M▲ 13.8%
-20.75M▲ 0%
FCF Margin %
-111.13%-91.49%-135.29%-36.88%-37.1%-19.2%-27.45%-16.99%-17.26%-35.24%
FCF Growth %
29.45%-12.39%-52.45%-37.07%28.92%29.92%-34.67%52.5%13.76%-156.07%
FCF per Share
-169.22-166.94-199.44-71.71-11.85-5.59-6.21-2.38-15.78-11.16
FCF Conversion (FCF/Net Income)
0.74x1.08x1.00x0.97x0.35x0.86x0.62x0.35x0.24x0.38x
Interest Paid
1.74M1.5M1.76M6.17M1.47M3.29M4.15M4.47M1.61M-23K
Taxes Paid
56K28K35K1.09M941K116K329K124K128K31K

VERO Key Ratios

Venus Concept Inc. (VERO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201620172018201920202021202220232024TTM
Return on Equity (ROE)
--135.23%-305.63%-98.73%-135.68%-53.92%-173.64%--1655.95%-1742.63%
Return on Invested Capital (ROIC)
--489.11%-335.02%-32.68%-46.49%-12.47%-30.86%-29.95%-39.8%-71.61%
Gross Margin
33.13%42.95%43.3%69.43%65.87%70.15%66.3%68.32%68.34%64.36%
Net Margin
-140.04%-83.78%-130.83%-36.79%-104.73%-21.79%-43.92%-48.79%-72.49%-92.76%
Debt / Equity
-0.99x3.47x0.90x1.82x1.87x9.59x-15.16x10.42x
Interest Coverage
-7.62x-8.53x-11.65x-4.01x-8.14x-2.98x-7.65x-4.11x-3.55x-9.69x
FCF Conversion
0.74x1.08x1.00x0.97x0.35x0.86x0.62x0.35x0.24x0.38x
Revenue Growth
-9.46%36.52%3.09%402.85%-29.34%35.39%-5.8%-23.26%-15.09%-12.39%
Related:VERO Dividend History·VERO Revenue History·VERO Price History·VERO P/E History·VERO Financial Ratios·VERO Institutional Holders

VERO Frequently Asked Questions

Venus Concept Inc. (VERO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Venus Concept Inc. (VERO) reported $58.9M in revenue for fiscal year 2024. This represents a 242% increase from $17.2M in 2015.

Venus Concept Inc. (VERO) saw revenue decline by 15.1% over the past year.

Venus Concept Inc. (VERO) reported a net loss of $54.6M for fiscal year 2024.

Dividend & Returns

Venus Concept Inc. (VERO) has a return on equity (ROE) of -1656.0%. Negative ROE indicates the company is unprofitable.

Venus Concept Inc. (VERO) had negative free cash flow of $20.7M in fiscal year 2024, likely due to heavy capital investments.

What if you invested $1,000 in VERO back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →

How much would $100/month in VERO be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →